HomeInsightsStock Comparison

3b Blackbio Dx Ltd vs Transgene Biotek Ltd Stock Comparison

3b Blackbio Dx Ltd vs Transgene Biotek Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1522 as of 22 Jul 15:30.
  • The P/E Ratio of 3B Blackbio DX Ltd changed from 7.1 on March 2020 to 20.5 on March 2024 . This represents a CAGR of 23.62% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of 3B Blackbio DX Ltd changed from ₹ 54.47 crore on March 2020 to ₹ 660.52 crore on March 2024 . This represents a CAGR of 64.72% over 5 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 22.81 crore on March 2020 to ₹ 61.68 crore on March 2024 . This represents a CAGR of 22.01% over 5 years.
  • The revenue of 3B Blackbio DX Ltd for the Mar '25 is ₹ 27.44 crore as compare to the Dec '24 revenue of ₹ 28.41 crore. This represent the decline of -3.41% The revenue of Transgene Biotek Ltd for the Mar '25 is ₹ 0.12 crore as compare to the Dec '24 revenue of ₹ 0.12 crore. This represent the decline of 0%.
  • The ebitda of 3B Blackbio DX Ltd for the Mar '25 is ₹ 12.86 crore as compare to the Dec '24 ebitda of ₹ 18.09 crore. This represent the decline of -28.91% The ebitda of Transgene Biotek Ltd for the Mar '25 is ₹ -0.5 crore as compare to the Dec '24 ebitda of ₹ -0.05 crore. This represent the growth of 900%.
  • The net profit of 3B Blackbio DX Ltd changed from ₹ 7.21 crore to ₹ 8.04 crore over 8 quarters. This represents a CAGR of 5.60% The net profit of Transgene Biotek Ltd changed from ₹ -0.13 crore to ₹ -0.71 crore over 8 quarters. This represents a CAGR of 133.70% .
  • The Dividend Payout of 3B Blackbio DX Ltd changed from 85.95 % on March 2020 to 7.52 % on March 2024 . This represents a CAGR of -38.57% over 5 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About 3B Blackbio DX Ltd

  • 3D Blackbio DX Ltd (Formerly known Kilpest India Ltd) was incorporated on May 25, 1972, as one of India's leading Agri-based companies.
  • Shri R.K. Dubey is the founder of this Company.
  • It was the only pesticide formulating company in the entire region of Madhya Pradesh in 1970s.
  • The company has now grown over the years and is leading today in Central India and manufactures about 50 pesticide products, microfertilizers, biofertilizers and biopesticides. The Company has representation in India in the field of agriculture business comprising crop protection, public health products and bio-products and is reputed reliable supplier to various Govt. organizations, such as Directorate General of Supplies & Transport, New Delhi, NAVY, Vishakapatnam/Mumbai, Food Corporation of India Raipur/ Bhopal/ Lucknow/ Mumbai/ Jaipur, NTPC, Bilaspur, Directorate of Health Service, M.

About Transgene Biotek Ltd

  • Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India.
  • Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
  • The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

3B Blackbio DX Ltd News Hub

News

3B BlackBio Dx announces demise of director

3B BlackBio Dx announced the sad demise of Rajesh Dubey (DIN: 10738590), Independent Direc...

Read more

15 Jul 2025 14:14

News

3B Blackbio DX Ltd leads losers in 'B' group

Denta Water & Infra Solutions Ltd, Delta Manufacturing Ltd, Alpa Laboratories Ltd and Asho...

Read more

29 May 2025 14:45

News

Board of 3D Blackbio DX recommends final dividend

3D Blackbio DX announced that the Board of Directors of the Company at its meeting held on...

Read more

28 May 2025 18:27

News

3D Blackbio DX to hold board meeting

3D Blackbio DX will hold a meeting of the Board of Directors of the Company on 28 May 2025...

Read more

20 May 2025 17:24

News

3D Blackbio DX to conduct board meeting

3D Blackbio DX will hold a meeting of the Board of Directors of the Company on 13 February...

Read more

04 Feb 2025 16:16

News

3D Blackbio DX announces board meeting date

3D Blackbio DX will hold a meeting of the Board of Directors of the Company on 13 November...

Read more

04 Nov 2024 18:41

Transgene Biotek Ltd News Hub

News

Transgene Biotek announces board meeting date

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 7 May 202...

Read more

28 Apr 2025 09:22

News

Transgene Biotek declare Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 24 Januar...

Read more

17 Jan 2025 11:58

News

Transgene Biotek to announce Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 Novemb...

Read more

05 Nov 2024 12:01

News

Transgene Biotek to hold board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 10 August...

Read more

20 Jul 2024 12:06

News

Transgene Biotek schedules board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 30 May 20...

Read more

13 May 2024 11:11

News

Transgene Biotek to conduct board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 14 Februa...

Read more

30 Jan 2024 14:56

SWOT Analysis Of Transgene Biotek Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of 3B Blackbio DX Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Transgene Biotek Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for 3B Blackbio DX Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of 3B Blackbio DX Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Transgene Biotek Ltd?

Market cap of 3B Blackbio DX Ltd is 1,306 Cr while Market cap of Transgene Biotek Ltd is 36 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Transgene Biotek Ltd?

The stock performance of 3B Blackbio DX Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Transgene Biotek Ltd?

As of July 22, 2025, the 3B Blackbio DX Ltd stock price is INR ₹1522.1. On the other hand, Transgene Biotek Ltd stock price is INR ₹4.83.

How do dividend payouts of 3B Blackbio DX Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions